Are you Dr. Maynard?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 46 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5200 Eastern Ave
Mason F. Lord Building Center Tower, Suite 4100
Baltimore, MD 21224Phone+1 410-614-3368Fax+1 410-550-2072- Is this information wrong?
Summary
- Dr. Janet Maynard, MD is a rheumatologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland. She is an Assistant Professor at Johns Hopkins University School of Medicine.
Education & Training
- Johns Hopkins UniversityFellowship, Rheumatology, 2007 - 2010
- Duke University HospitalResidency, Internal Medicine, 2004 - 2007
- Vanderbilt University School of MedicineClass of 2004
Certifications & Licensure
- MD State Medical License 2010 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 30 citationsUsing four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncolo...Kathleen L. Miller, Lewis J. Fermaglich, Janet W. Maynard> ;Orphanet Journal of Rare Diseases. 2021 Jun 9
- 6 citationsImpact of Sex on Clinical Response in Rheumatoid Arthritis Patients Treated With Biologics at Approved Dosing Regimens.Lanyan Fang, Xuyang Song, Ping Ji, Yaning Wang, Janet Maynard, Sarah Yim, Chandrahas G. Sahajwalla, Mingjiang Xu, Myong-Jin Kim, Liang Zhao> ;Journal of Clinical Pharmacology. 2020 Dec 3
- 9 citationsFDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development.Kathleen L. Miller, Christine M. Mueller, Gumei Liu, Katherine I. Miller Needleman, Janet W. Maynard> ;Orphanet Journal of Rare Diseases. 2020 Sep 3
- Join now to see all
Press Mentions
- FDA Approves New Menopause Drug to Treat Hot FlashesMay 16th, 2023
- FDA Approves Veozah, First-of-Its-Kind Drug To Treat Hot FlashesMay 13th, 2023
- What to Know About the New Treatment for Hot FlashesMay 12th, 2023
- Join now to see all